Background
==========

Heterotrimeric guanine nucleotide-binding proteins (G proteins) are multifaceted signaling modules that relay extracellular signals detected by G protein-coupled receptors (GPCRs) to intracellular effector \[[@B1]-[@B3]\]. At the core of the G protein signal transduction machinery is the Gα subunit, a GTPase which acts as a timer to limit the activation signal. In the classical G protein activation cycle, the Gα subunit needs to associate with the Gβγ dimer, the GPCR, and effectors separately or simultaneously at different stages of the cycle. A variety of accessory proteins are now known to modulate the fidelity of the G protein signal. They include regulators of G protein signaling (RGS) \[[@B4]\], activators of G protein signaling (AGS) \[[@B5]\], and adaptor proteins such as tetratricopeptide repeat 1 (TPR1) \[[@B6]\]. These additional components allow for rapid inactivation or receptor-independent activation of the Gα subunit, as well as signal diversification. The large number of different types of binding partners for the Gα subunit requires optimal utilization of structural domains that are available for protein-protein interactions. Given that Gα subunits are typically less than 50 kDa in size and are attached to the inner leaflet of the plasma membrane, the binding surfaces available for interaction are limited. Nature has partially resolved this constraint by generating different conformations of the Gα subunit through the binding and hydrolysis of GTP.

The resolution of the crystal structures of several Gα subunits in their GDP- or GTP-bound states \[[@B7],[@B8]\] and as complexes with the Gβγ dimer \[[@B9]-[@B11]\] or other interacting proteins \[[@B12]-[@B17]\] have provided valuable insight into the molecular mechanisms of G protein signal transduction. Structurally, the Gα subunit can be broadly divided into the GTP hydrolase (GTPase) and helical domains (Figure [1](#F1){ref-type="fig"}) with the former harboring the GTP-binding pocket \[[@B18],[@B19]\]. Several regions (Switch I-IV) spreading across the GTPase and helical domains exhibit profound conformational changes when the Gα subunit shifts between the GDP- and GTP-bound states \[[@B20],[@B21]\]. Changes in the switch regions provide the molecular basis of G protein activation and effector regulation. In the GTP-bound active state, the Gα subunit releases the Gβγ dimer and thus allows effectors to bind to the newly exposed surfaces such as the Switch II region \[[@B20],[@B21]\]. This simplistic view, however, cannot accommodate the increasing numbers of Gα-interacting proteins. The activated Gα subunit is a preferred partner for multiple effectors, adaptors, and RGS proteins. A central question is whether an activated Gα subunit can concurrently regulate multiple signaling pathways by simultaneously binding to different partners in much the same way as an inactive Gα subunit forms a complex with the Gβγ dimer and the receptor.

![**Structural representations of the functional domains of Gα~q~**. The crystal structure of Gα~q~(based on the complex with p63RhoGEF and RhoA, PDB ID: [2rgnA](2rgnA)) is depicted with the different functional domains highlighted. The top left panel is the Gα~q~structure in rainbow colors (blue to red as from N- to C-terminus). Nomenclature of α helices and β strands is according to the first resolved Gα crystal structure \[[@B19]\]. The dotted line divides the structure into two parts, known as the helical and GTPase domains. The other five structures are shown in the same orientation as the top left panel, with the putative interacting domains for Gβγ (green), PLCβ (yellow), p63RhoGEF (p63, light blue), GRK2 (orange) and RGS2 (magenta) highlighted. Mapping of the various interacting domains are based on resolved crystal structures (for Gβγ, PLCβ, p63RhoGEF and GRK2) or structural alignment with other Gα subunit complex structures (for RGS2 in complex with Gα~i3~). The bottom panel is a simplified linear representation of Gα~q~with the secondary structures belonging to helical (light blue) and GTPase domains (light green) highlighted; α-helices and β-strands are depicted as rectangles and ovals, respectively. The N-terminal helix colored in red remains unresolved in the crystal structure of Gα~q~. The corresponding functional domains of the five interacting partners as shown in the molecular models above the schematic are indicated with the same color scheme.](1472-6807-11-17-1){#F1}

Among the different subfamilies of Gα subunits, members of the Gα~q~subfamily have the capacity to activate phospholipase Cβ (PLCβ) \[[@B22],[@B23]\] as well as interact with the guanine nucleotide exchange factor p63RhoGEF \[[@B24],[@B25]\], G protein-coupled receptor kinase GRK2 \[[@B26]-[@B28]\], adaptor proteins such as TPR1 \[[@B6]\], and several RGS proteins \[[@B29]-[@B32]\]. These molecules bind to overlapping as well as distinct regions on Gα~q~(Figure [1](#F1){ref-type="fig"}). It is often assumed that the primary signal generated by G~q~-coupled receptors is the formation of inositol trisphosphates (IP~3~) by PLCβ, and that the regulation of downstream kinases and transcription factors are consequential to the production of IP~3~and the subsequent Ca^2+^mobilization. However, recent studies suggest that Gα subunits can concurrently regulate multiple signaling pathways. The ability of Gα~16~, a member of the Gα~q~subfamily, to interact with the adaptor protein TPR1 \[[@B6]\] has raised some interesting scenarios. Gα~16~is primarily expressed in hematopoietic cells and it can regulate multiple signaling pathways \[[@B25],[@B33]\]. Interestingly, TPR1 can directly interact with Ras especially when the latter is activated \[[@B6]\] and it appears to link Gα~16~to Ras activation \[[@B34]\]. Ras is a small GTPase which acts as a molecular switch for linking various cell surface receptors to intracellular signaling pathways, resulting in cell proliferation and differentiation \[[@B35]\]. We have recently demonstrated that constitutively active Gα~16~(Gα~16~QL) induces the phosphorylations of transcription factors, such as signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB (NFκB), through PLCβ and Ras/Raf-1/MEK/ERK signaling cascades in human embryonic kidney 293 (HEK 293) cells \[[@B36],[@B37]\]. However, it is not known if the binding of TPR1 to Gα~16~affects PLCβ signaling and whether TPR1 and PLCβ utilize the same docking site on Gα~16~. Although Gα~16~has been shown to interact with the C-terminus of TPR1 \[[@B6]\], the structural requirement for Gα~16~to interact with TPR1 has yet to be defined. In the present study, we examined the structural domain of Gα~16~for interacting with TPR1 and assessed whether the same domain is responsible for regulating PLCβ.

Methods
=======

Materials
---------

The human cDNAs of Gα~16~, Gα~16~QL, Gα~z~and Gα~z~QL were obtained from Missouri S&T cDNA Resource Center. C25 and C44 cDNAs were previously constructed and characterized \[[@B38]\]. Cell culture reagents, including Lipofectamine™ and Plus™ reagents, and AccuPrime™ *Pfx*SuperMix were purchased from Invitrogen (Carlsbad, CA). Anti-Gα~16~(N-terminus) and anti-Gα~z~(C-terminus) were obtained from Gramsch Laboratories (Schwabhausen, Germany). Anti-Gα~16~(C-terminus) was purchased from Torrey Pines Biolabs (East Orange, NJ). Anti-Gα~z~(N-terminus) and PLCβ antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). Unbound and affinity gel-conjugated anti-FLAG antibody were from Sigma-Aldrich (St. Louis, MO). Other antibodies were purchased from Cell Signaling Technology (Danvers, MA). Protein G-agarose and protein cross-linking agent dithiobis\[succinimidylpropionate\] were from Pierce Biotechnology (Rockford, IL). ECL kit was from GE Healthcare Bio-Sciences (Piscataway, NJ). Ras activation kit was a product of Millipore (Billerica, MA).

Construction of chimeras
------------------------

Gα chimeras were constructed from the cDNAs encoding the human Gα~16~and Gα~z~by using PCR techniques. The N-terminal 102, 155, 188, 200, 210, 246, 266 and 295 residues of Gα~16~were substituted by the corresponding regions of Gα~z~to generate N102, N155, N188, N200, N210, N246, N266 and N295 chimeras, respectively. Primer pairs were designed to cover the overlapping regions in forward and reversed directions. For each construct, the 5\' fragment was generated with the reversed and T7 primers, whereas the 3\' fragment was made with the forward and SP6 primer. The two half-products were then annealed together to generate a full-length fragment by another round of PCR using T7 and SP6 primers. Mirror-images of these constructs were generated analogously and were named C164, C174, C186, C219 and C272 chimeras. Primers for chimera construction are listed in Table [1](#T1){ref-type="table"}. PCR was carried out using AccuPrime™ *Pfx*SuperMix (30 cycles each with 94°C for 60 s, 58°C for 60 s and 72°C for 90 s). The N200-C164 and N188-C164 chimeras were constructed using C164 as the initial template for the 3\' half-products and those primers designed for N200 and N188, respectively. Likewise, zβ3 and zβ2β3 were constructed using the C174 and C164 primers with N210 as the initial templates. All chimeras were checked by restriction mapping and then subcloned into pcDNA3 at *Hind*III and *Xho*I sites. The constructs were fully sequenced by dideoxynucleotide sequencing to confirm the identities.

###### 

Primer sequences for constructing chimeras between Gα~16~and Gα~z~.

  *Construct*   *Primers:*                                     *Antisense Primer Sense Primer*
  ------------- ---------------------------------------------- ---------------------------------
  N102          `5`\'`-GGGCCTGCTGAATGG GATCCTGAGGGCGGC -3`\'   365
                `3`\'`-CCCGGACGACTTACCCTAGGACACCCGCCG-5`\'     
  N155          `5`\'`-GGCTGAATCGAGCAGGTGGTACTCGCTGGA-3`\'     367
                `3`\'`-CCGACTTAGCTCGTCCACCATGAGCGACCT-5`\'     
  N188          `5`\'`-GTTGATGCCAGTGGTCATGTCCCGGGAGCG-3`\'     367
                `3`\'`-CAACTACGGTCACCAGTACAGGGCCCTCGC-5`\'     
  N200          `5`\'`-CCGCAGGTTGGTTTTCTTGAAGGTGAACTT-3`\'     367
                `3`\'`-GGCGTCCAACCAAAAGAACTTCCACTTGAA-5`\'     
  N210          `5`\'`-CTCTGACTTCTGGCCCCCCACGTCCACCAT-3`\'     367
                `3`\'`-GAGACTGAAGACCGGGGGGTGCAGGTGGTA-5`\'     
  N210QL        `5`\'`-CTCTGACTTCAGGCCCCCCACGTCCACCAT-3`\'     367
                `3`\'`-GAGACTGAAGTCCGGGGGGTGCAGGTGGTA-5`\'     
  N246          `5`\'`-CATGCGGTTCTCCTGGTTATCCTCGTAGAG-3`\'     367
                `3`\'`-GTACGCCAAGAGGACCAATAGGAGCATCTC-5`\'     
  N266          `5`\'`-GGATGTGCTTTTGAACCAGTTGTTGTTGCA-3`\'     367
                `3`\'`-CCTACACGAAAACTTGGTCAACAACAACGT-5`\'     
  N295          `5`\'`-GCCCTGGAAACTGGGAAAGCAGATGGTGAG-3`\'     367
                `3`\'`-CGGGACCTTTGACCCTTTCGTCTACCACTC-5`\'     
  C164          `5`\'`-CTCTGACCTCTGCCCCCCGACGTCCACGAT-3`\'     362
                `3`\'`-GAGCAYGGAGACGGGGGGCTGCAGGTGCTA-5`\'     
  C164QL        `5`\'`-CTCTGACCTCAGCCCCCCGACGTCCACGAT-3`\'     362
                `3`\'`-GAGCATGGAGTCGGGGGGCTGCAGGTGCTA-5`\'     
  C174          `5`\'`-CTTGAAGGTGAGCTCCTGCACGGAGAAGCA-3`\'     362
                `3`\'`-GAACTTCCACTCGAGGACGTGCCTCTTCGT-5`\'     
  C186          `5`\'`-CACAATGCCCGTGGTGGGCATGCGGCTGCG-3`\'     362
                `3`\'`-GTGTTACGGGCACCACCCGTACGCCGACGC-5`\'     
  C219          `5`\'`-CGCGTTGTCCTCCAGGTGGAATTCCCGCCG-3`\'     362
                `3`\'`-GCGCAACAGGTCCACCACCTTAAGGGCGGC-5`\'     
  C272          `5`\'`-CTTGATTTCGCGGCGGTGGTCCTGCTTCTG-3`\'     362
                `3`\'`-GAACTAAAGCGCCGCCACCAGGACGAAGAC-5`\'     

Bold and italic nucleotides denote the Gα~16~-derived sequences.

Cell culture and co-immunoprecipitation experiments
---------------------------------------------------

HEK 293 cells were obtained from the American Type Culture Collection (CRL-1573, Rockville, MD). They were maintained in Eagle\'s minimum essential medium at 5% CO~2~, 37°C with 10% fetal bovine serum (FBS), 50 units/ml penicillin and 50 μg/ml streptomycin. HEK 293 cells were grown to 80% confluency in 100-mm tissue culture plates and then co-transfected with 800 ng Gα and 800 ng FLAG-TPR1 cDNAs using 15 μl Plus™ and Lipofectamine™ reagents in Opti-MEM™. FBS was replenished 3 h after transfection. Cross-linking was performed one day after transfection. Transfected cells were washed with PBS twice and then treated with 0.5 mM dithiobis\[succinimidylpropionate\] in PBS for 15 min at room temperature. Cells were then washed again with PBS and maintained in quenching solution (50 mM glycine in PBS, pH 7.4) for 5 min. Subsequently, cells were lysed in ice-cold RIPA buffer (25 mM HEPES at pH 7.4, 0.1% SDS, 1% Igepal CA-630, 0.5% sodium deoxycholate, 1 mM dithiothreitol, 200 μM Na~3~VO~4~, 4 μg/ml aprotinin, 100 μM phenylmethylsulfonyl fluoride, and 2 μg/ml leupeptin). Cell lysates were gently rocked with an anti-Gα~16~, anti-Gα~z~or anti-PLCβ antiserum at 4°C overnight, and then incubated in 30 μl protein G-agarose (50% slurry) at 4°C for 2 h. Alternatively, the cell lysates were incubated in 30 μl anti-FLAG affinity agarose gel (50% slurry) at 4°C overnight. Immunoprecipitates were washed with ice-cold RIPA buffer (400 μl) for four times, resuspended in 50 μl RIPA buffer and 10 μl 6 × sample buffer and then boiled for 5 min. Gα~16~, Gα~z~, PLCβ and FLAG-TPR1 proteins in the immunoprecipitates were analyzed by Western blots.

Ras activation assay
--------------------

HEK 293 cells were co-transfected with 800 ng Gα, 800 ng FLAG-TPR1 and 400 ng Ras cDNAs. After 1 day, transfectants were serum-deprived for 4 h. Cells were then washed twice with ice-cold PBS and lysed with the 1 × Mg^2+^lysis buffer (MLB: 25 mM HEPES at pH 7.5, 150 mM NaCl, 1% Igepal CA-630, 10 mM MgCl~2~, 1 mM EDTA, 2% glycerol, 200 μM Na~3~VO~4~, 4 μg/ml aprotinin and 2 μg/ml leupeptin). Cell lysates were pre-cleaned with Protein G-agarose and activated Ras was immunoprecipitated with 20 μl Raf-1 Ras-binding domain-conjugated agarose (Millipore) for 45 min and followed by three washes of 400 μl ice-cold MLB. Immunoprecipitates was finally reconstituted in 50 μl MLB and 10 μl 6 × sample buffer and resolved in SDS-PAGE for detecting Ras using specific antibody.

Assays for phosphorylated ERK, IKK and STAT3
--------------------------------------------

HEK 293 cells were seeded on a 6-well plate at 4.5 × 10^5^cells/well 1 day prior to transfection. Transfection was performed with 200 ng Gα and 200 ng FLAG-TPR1 cDNAs using 4 μl Plus™ and Lipofectamine™ reagents in Opti-MEM™. The transfectants were serum-deprived overnight one day after transfection. Cells were treated with pertussis toxin (PTX; 100 ng/ml for 16 h) and *N*^6^-cyclohexyladenosine (CHA; 10 μM for 15 min) where appropriate, lysed, and then assayed for phosphorylation statuses of ERK, STAT3, and IKK as described previously \[[@B36],[@B37]\].

Inositol trisphosphate accumulation assay
-----------------------------------------

HEK 293 cells were seeded on a 12-well plate at 2 × 10^5^cells/well one day prior to transfection. Cells were transfected with 300 ng Gα with or without 200 ng type 1 adenosine receptor (A~1~R) cDNAs using 2 μl Lipofectamine™ 2000 reagent in Opti-MEM™ containing 5% FBS. Transfectants were labeled with 2.5 μCi/ml *myo*-\[^3^H\]inositol and subsequently assayed for CHA-induced \[^3^H\]IP~3~formation as described previously \[[@B39]\].

NFκB-driven and STAT3-driven luciferase assays
----------------------------------------------

For STAT3-driven luciferase assay \[[@B40]\], HEK 293 cells were seeded on a 96-well microplate at 10,000 cells/well one day before transfection. Cells were transfected with 10 ng Gα and 100 ng pSTAT3-luc luciferase reporter using 0.2 μL Plus™ and Lipofectamine™ reagents in Opti-MEM™ and FBS was replenished after 3 h. When A~1~R-induced signals were analyzed, 10 ng receptor cDNA was included in the transfection. For NFκB-driven luciferase assay, HEK 293 cells stably transfected with pNFκB-luc luciferase reporter were seeded on a 96-well microplate at 15,000 cells/well. The setup and transfection were as described previously \[[@B36]\]. One day after transfection, transfectants were serum-deprived for 4 h and PTX (100 ng/ml) was added where necessary. Cells were challenged with or without 10 μM CHA for 16 h before measuring the luciferase activity as reported previously \[[@B36]\].

Western blotting analysis
-------------------------

Protein samples were resolved on 12% SDS-PAGE and transferred to nitrocellulose membrane (GE Osmonics). Resolved proteins were detected by their specific primary antibodies and horseradish peroxidase-conjugated secondary antisera. The immunoblots were visualized by chemiluminescence with the ECL kit from GE Healthcare Bio-Sciences, and the images detected in X-ray films were quantified by densitometric scanning using the Eagle Eye II gel documentation system (Stratagene, La Jolla, CA, USA).

Molecular modeling of Gα subunits
---------------------------------

Gα~q~in the complex with p63RhoGEF and RhoA (PDB ID: [2rgnA](2rgnA)) \[[@B13]\] was employed for the illustration of functional domains of Gα~q~, and for creating a molecular model of Gα~16~by homologous modeling using SWISS-MODEL \[[@B41]\], which allowed manual adjustments to the alignment of the sequences of Gα~16~with Gα~q~in order to accommodate the extraordinarily long α4/β6 loop of Gα~16~. Molecular models of Gα~z~with or without the mutations at β2/β3 loop (^194^ELTFKM → KTNLRI) were generated using 3D-JIGSAW \[[@B42]\] based on the crystal structure of Gα~i1~bound to AlF~4~^-^and GDP (PDB ID: [2hlbA](2hlbA)) \[[@B43]\] as selected by the default automatic mode. 3D-JIGSAW-generated models showed greater dynamics in the loop structures and allowed for the exploration of potential conformational variations caused by the mutations. Visualization of various structures was accomplished using UCSF Chimera \[[@B44]\].

Results
=======

Extreme termini of Gα~16~are not involved in TPR1 interaction
-------------------------------------------------------------

Unlike the receptor-interacting domain which is composed of five distinct structures \[[@B45]-[@B47]\], no discrete localization for effector interaction is generally applicable to the Gα subunits, probably because the different signaling pathways entail a diverse spectrum of effector molecules. The Gα~16~regions responsible for effector interaction have not been mapped, but there is evidence to suggest that the Switch III and the α3 helix may participate in the binding of p63RhoGEF \[[@B48]\] and that the PLCβ-interacting domain on Gα~q~mainly encompasses the α2-β4-α3-β5 regions \[[@B49]\]. The involvement of β2 strand, α2 and α3 helices in the Gα~q~/PLCβ complex formation has been revealed clearly in the very recently resolved crystal structure \[[@B50]\] which also confirmed that PLCβ can serve as a GAP for Gα~q~\[[@B51]\]. In order to identify the structural domains on Gα~16~that interact with TPR1, Gα~16~sequences were progressively replaced by those of Gα~z~because the latter does not recognize TPR1 (Figure [2B](#F2){ref-type="fig"}). Chimeras composed of Gα~16~and Gα~z~residues were preferred because they are structurally viable \[[@B38]\]. A series of chimeras was made by swapping discrete regions between Gα~16~and Gα~z~. Construction of the chimeras was guided by the predicted tertiary structure of the Gα subunits as well as by our previous experience in determining the receptor and effector interacting domains of Gα~16~and Gα~z~\[[@B38],[@B52]-[@B55]\]. For chimeras with substitutions at either the N- or C-terminus, they were named with a single letter (N or C) followed by the numbers of amino acids of Gα~z~that substituted the corresponding regions of Gα~16~. The two chimeras containing either β2 or β2-β3 strands of Gα~z~were named with the a letter \"z\" followed by \"β2\" or \"β2β3\", respectively, in order to distinguish them from the descriptions of specific β strand structures.

![**Extreme termini of Gα~16~are not required for TPR1 interaction**. (A) Schematic representation of the C25, C44, and N30 chimeras. Predicted secondary structures are illustrated as boxes (α helices) or ovals (β strands) above the chimeras. Closed areas represent human Gα~16~sequence while those in open shapes signify the corresponding sequence of human Gα~z~. (B-D) HEK 293 cells were transiently co-transfected with FLAG-TPR1 and the wild-type or constitutively active mutants of Gα~16~, Gα~z~, C25, C44, N30, or pcDNA1. Cell lysates from the transfectants were immunoprecipitated (IP) by anti-FLAG affinity agarose gel (upper panels), anti-Gα~16~or anti-Gα~z~antiserum (middle panels). The immunoprecipitates were immunoblotted with anti-Gα~16~, anti-Gα~z~, or anti-FLAG antiserum. Aliquots of cell lysates were used to detect the expression levels of Gα~16~, Gα~z~and FLAG-TPR1 by western blot analysis (lower panels). Data shown represent one of three sets of immunoblots; two other sets yielded similar results.](1472-6807-11-17-2){#F2}

We first examined two chimeras of Gα~16~containing either 25 or 44 amino acids of Gα~z~at the C-terminus; representing changes in the α5 helix alone and α4/β6 loop plus the α5 helix, respectively. These two chimeras, named C25 and C44 respectively (Figure [2A](#F2){ref-type="fig"}), have been previously constructed and characterized (equivalent to the 16z25 and 16z44 of \[[@B38]\], respectively). Both chimeras exhibit enhanced coupling to G~i~-coupled receptors and possess the ability to stimulate PLCβ. HEK 293 cells were co-transfected with FLAG-TPR1 in combination with pcDNA1, Gα~16~, C25 or C44. As illustrated in Figure [2C](#F2){ref-type="fig"} (upper panels), Gα~16~, C25 and C44 were co-immunoprecipitated with the anti-FLAG affinity gel with similar levels of FLAG-TPR1. Moreover, FLAG-TPR1 was coimmunoprecipitated along with Gα~16~, C25 or C44 (Figure [2C](#F2){ref-type="fig"}, middle panels). Gα~16~, C25, C44 and FLAG-TPR1 were expressed at detectable and comparable levels in the transfectants (Figure [2C](#F2){ref-type="fig"}, lower panels). Since both chimeras retained the ability to interact with FLAG-TPR1, it implies that the C-terminal β6 and α5 regions of Gα~16~are not required for the interaction with TPR1.

The N-terminus of Gα subunits participates in membrane attachment, Gβγ binding as well as receptor recognition. Another previously constructed chimera, N30 \[[@B38]\], was employed to test the possible involvement of the N-terminus of Gα~16~in TPR1-binding. The αN helix (first 30 amino acids) of N30 is composed of Gα~z~sequence (Figure [2A](#F2){ref-type="fig"}). As shown in Figure [2D](#F2){ref-type="fig"} (upper panels), both Gα~16~and N30 co-immunoprecipitated with FLAG-TPR1 and similar levels of FLAG-immunoreactivity were observed. Similarly, FLAG-TPR1 co-immunoprecipitated with Gα~16~and N30 and the levels of these Gα subunits in the immunoprecipitates were essentially the same (Figure [2D](#F2){ref-type="fig"}, middle panels). Like Gα~16~QL, constitutively active N30QL was more readily associated with TPR1 (Figure [2D](#F2){ref-type="fig"}, upper and middle panels) and this effect was not due to variations in expression levels (Figure [2D](#F2){ref-type="fig"}, lower panels). Given that N30 still possessed the ability to interact with FLAG-TPR1, our results suggest that the region which is critical for direct or indirect binding of TPR1 may lie between the β1 strand and α4 helix of Gα~16~.

The β3 region of Gα~16~interacts with TPR1
------------------------------------------

To further examine the structural domain of Gα~16~for TPR1 interaction, additional chimeras were constructed by replacing different regions of Gα~16~with those of Gα~z~. Four different chimeras named N210, N246, N266 and N295 were thus constructed (Figure [3A](#F3){ref-type="fig"}) by replacing a Gα~z~backbone with Gα~16~sequences starting from the α2, α3, β5, and α4 regions, respectively. However, none of the four Gα~16~chimeras could be pulled down by anti-FLAG affinity gel (Figure [3B](#F3){ref-type="fig"}, upper panels). Similarly, FLAG-TPR1 could not be co-immunoprecipitated by anti-Gα~16~antiserum in chimera-expressing cells (Figure [3B](#F3){ref-type="fig"}, middle panels) despite detectable expression levels of FLAG-TPR1 and the chimeras in the cell lysates (Figure [3B](#F3){ref-type="fig"}, lower panels). In control experiments, both Gα~16~and Gα~16~QL were co-immunoprecipitated with FLAG-TPR1 (Figure [3B](#F3){ref-type="fig"}). These findings demonstrate that the TPR1-interacting domain must reside between residues 30 and 210 that represent the regions from β1 to β3 of Gα~16~.

![**Localization of the TPR1-interacting domain to the αE-αF-β2-β3 regions of Gα~16~**. (A) Schematic representation of the N102, N155, N210, N246, N266, and N295 chimeras. (B-C) HEK 293 cells were transiently co-transfected with FLAG-TPR1 and the wild-type or constitutively active mutants of Gα~16~, N102, N155, N210, N246, N266, N295, or pcDNA1. Co-immunoprecipitation assays were performed and analyzed as in Figure 2. Data shown represent one of three sets of immunoblots; two other sets yielded similar results.](1472-6807-11-17-3){#F3}

Two more chimeras were constructed to map the TPR1-interacting domain within the first 30-210 residues. Chimeras N102 and N155 were made by replacing the N-terminus of Gα~16~with Gα~z~sequences up to and including the αA and αD regions, respectively (Figure [3A](#F3){ref-type="fig"}). Both N102 and N155 were found to co-immunoprecipitate with FLAG-TPR1 (Figure [3C](#F3){ref-type="fig"}, upper panels). Association of these two chimeras with FLAG-TPR1 was confirmed by reverse co-immunoprecipitation using the anti-Gα~16~antiserum (Figure [3C](#F3){ref-type="fig"}, middle panels). These results narrowed down the TPR1-interacting domain of Gα~16~to be among the αE to β3 regions.

Before pinpointing the precise location of the TPR1-interacting site on Gα~16~, we first confirmed the preceding observations with additional chimeras that represent the mirror images of several tested chimeras. Chimeras C272, C219, and C164 were essentially the mirror images of N102, N155, and N210, respectively (Figure [4A](#F4){ref-type="fig"}), and they should exhibit phenotypes opposite to those of their counterparts. Indeed, C272 and C219 could not associate with FLAG-TPR1 even though they were efficiently expressed (Figure [4B](#F4){ref-type="fig"}). Conversely, chimera C164 should be able to interact with FLAG-TPR1 because its mirror image (N210) failed to associate with FLAG-TPR1; co-immunoprecipitation of C164 and FLAG-TPR1 confirmed their association (Figure [4B](#F4){ref-type="fig"}). These results again indicate that the TPR1-interacting domain of Gα~16~lies within the αE-αF-β2-β3 regions which are common in N102, N155, and C164 but missing in their corresponding mirror images (Figures [5A](#F5){ref-type="fig"} and [6A](#F6){ref-type="fig"}).

![**Localization of the TPR1-interacting domain to the αE-αF-β2-β3 regions of Gα~16~**. (A) Schematic representation of the C272, C219, and C164 chimeras. (B) HEK 293 cells were transiently co-transfected with FLAG-TPR1 and the wild-type or constitutively active mutants of Gα~16~, C272, C219, C164, or pcDNA1. Co-immunoprecipitation assays were performed and analyzed as in Figure 2. Data shown represent one of three sets of immunoblots; two other sets yielded similar results.](1472-6807-11-17-4){#F4}

![**Identification of the β3 region as the TPR1-interacting site of Gα~16~**. (A) Schematic representation of the C186, N188, C174, and N200 chimeras. (B-C) HEK 293 cells were transiently co-transfected with FLAG-TPR1 and the wild-type or constitutively active mutants of Gα~16~, C186, N188, C174, N200, or pcDNA1. Co-immunoprecipitation assays were performed and analyzed as in Figure 2. Data shown represent one of three sets of immunoblots; two other sets yielded similar results.](1472-6807-11-17-5){#F5}

![**Confirmation of the β3 region as a TPR1-interacting site of Gα~16~**. (A) Schematic representation of the N200-C164, N188-C164, zβ2β3, and zβ3 chimeras. (B-C) HEK 293 cells were transiently co-transfected with FLAG-TPR1 and the wild-type or constitutively active mutants of Gα~16~, N200-C164, N188-C164, zβ2β3, zβ3 or pcDNA1. Co-immunoprecipitation assays were performed and analyzed as in Figure 2. Data shown represent one of three sets of immunoblots; two other sets yielded similar results.](1472-6807-11-17-6){#F6}

To tease out the TPR1-interacting domain, two new constructs were made by dissecting the αE-αF-β2-β3 regions into two halves. C186 contained the N-terminal half of Gα~16~up to and including the αE-αF regions, while N188 represented its mirror image and contained Gα~16~-specific sequence from the β2-β3 regions onward (Figure [5A](#F5){ref-type="fig"}). Because these two mirror images contained completely different regions of Gα~16~and Gα~z~, two distinct anti-Gα~16~antisera, targeting either the extreme N-terminus (Gα~16~N) or C-terminus (Gα~16~C), were required in the co-immunoprecipitation assay. Although both mutants were expressed to comparable levels (Figure [5B](#F5){ref-type="fig"}, bottom panels), only N188 (as well as its QL mutant) was co-immunoprecipitated with FLAG-TPR1 (Figure [5B](#F5){ref-type="fig"}, upper panels). For the reverse co-immunoprecipations, N188 and N188QL, but not C186 and its mutant, were able to interact with TPR1 (Figure [5B](#F5){ref-type="fig"}, middle panels). Since these findings suggest that only β2-β3 within the αE-αF-β2-β3 region is responsible for TPR1 association, two more chimeras (C174 and N200) were created to split this region into two halves (Figure [5A](#F5){ref-type="fig"}); C174 possessed Gα~16~-specific β2 region whereas N200 harbored the Gα~16~-specific β3 region. Co-immunoprecipitation experiments with FLAG-TPR1 illustrated that N200 and its constitutively active mutant N200QL interacted with FLAG-TPR1 while C174 and C174QL were ineffective (Figure [5C](#F5){ref-type="fig"}). Reverse co-immunoprecipitations with anti-Gα~16~antisera confirmed the ability of TPR1 to associate with N200 and N200QL.

In order to validate the importance of the β3 region of Gα~16~for TPR1 interaction, N188-C164 and N200-C164 were constructed as shown in Figure [6A](#F6){ref-type="fig"}. N188-C164 is primarily a Gα~z~backbone with the β2 and β3 regions from Gα~16~, while N200-C164 is essentially Gα~z~with the β3 region made up of the Gα~16~sequence. Co-immunoprecipitation experiments using anti-FLAG or anti-Gα~z~antisera showed that both chimeras and their respective constitutively active mutants interacted with FLAG-TPR1 (Figure [6B](#F6){ref-type="fig"}). Association of N200-C164 with FLAG-TPR1 suggests that the β3 region of Gα~16~alone is sufficient to confer upon Gα~z~the ability to interact with TPR1. On the other hand, replacement of the β3 region of Gα~16~with the cognate sequence of Gα~z~is expected to disrupt Gα~16~/TPR1 interaction. Two additional chimeras, named zβ3 and zβ2β3, with either the β3 or β2-β3 regions of Gα~z~inserted into a Gα~16~backbone (Figure [6A](#F6){ref-type="fig"}) were constructed to test this hypothesis. zβ2β3 and zβ2β3QL failed to co-immunoprecipitate with TPR1 (Figure [6C](#F6){ref-type="fig"}), thus demonstrating the importance of the β2 and β3 regions of Gα~16~for interaction with TPR1. However, very weak but detectable associations of zβ3 and zβ3QL with FLAG-TPR1 were observed in co-immunoprecipitation assays (Figure [6C](#F6){ref-type="fig"}). These results confirm the crucial role of the β3 region for the Gα~16~/TPR1 interaction, and further suggest that the β2 region may facilitate the actions of the β3 strand.

Activation of Ras via the association of TPR1 with Gα~16~and its chimeras
-------------------------------------------------------------------------

Association of TPR1 with Ras may provide a more direct link for Gα~16~to activate the ERK cascade instead of going through the PLCβ/PKC pathway. If the β3 region of Gα~16~is essential for functional interaction with TPR1 and Ras, chimeras containing this region should facilitate the activation of Ras while those lacking this region ought to be inactive. As predicted, transfectants expressing N200QL (carrying the β3 region of Gα~16~) exhibited elevated Ras activity whereas C174QL (β3 region from Gα~z~) did not activate Ras (Figure [7A](#F7){ref-type="fig"}). To extend this study, other TPR1-interacting chimeras were evaluated (Figure [7B](#F7){ref-type="fig"}). No significant Ras activation was detected when wild-type N102, N155, N188 and C164 were overexpressed. Upon the introduction of the QL mutants of these chimeras, all chimeras induced detectable Ras activation as compared to their corresponding wild-type counterparts (Figure [7B](#F7){ref-type="fig"}). Likewise, N188-C164 and N200-C164 should be capable of activating Ras because they possess the β3 region of Gα~16~. Indeed, the constitutive active mutants of these chimeras activated Ras (Figure [7C](#F7){ref-type="fig"}). Conversely, zβ2β3 and zβ3 (the mirror images of N188-C164 and N200-C164, respectively) did not stimulate the Ras activity (Figure [7C](#F7){ref-type="fig"}). These results indicate that chimeras containing the Gα~16~-specific β3 region possess the ability to activate Ras, and such activity is dependent on the GTP-bound conformation of the chimeras.

![**Activation of Ras by the constitutively active mutants of the TPR1-interacting Gα chimeras**. (A) HEK 293 cells were transiently co-transfected with Ras, FLAG-TPR1 and the wild-type or constitutively active mutants of Gα~16~, C174, N200, pcDNA1 (A), N102, N155, N188, C164 (B), zβ3, zβ2β3, N188-C164, or N200-C164 (C). Cell lysates were immunoprecipitated with GST-bound Ras binding domain of Raf-1 (Raf-1^RBD^) agarose. The cell lysates and the eluted protein samples were subsequently immunoblotted against anti-Ras, anti-FLAG, and anti-Gα~16~or anti-Gα~z~antibody. The result of the densitometric analysis is shown above the immunoblots and the numerical values represent relative intensities of Ras activity expressed as a ratio of the basal (B), Gα~16~-mediated Ras activity (C) (set as 1.0). Data shown represent one of three sets of immunoblots; two other sets yielded similar results.](1472-6807-11-17-7){#F7}

Gα~16~QL-induced Ras activation is independent of PLCβ signaling
----------------------------------------------------------------

The PLCβ-interacting domain of Gα~q~was initially mapped to residues 217-276 \[[@B49]\], corresponding to the α2-β4-α3-β5 regions of Gα~16~. Recent resolution of the crystal structure of Gα~q~-PLCβ has refined the PLCβ-interaction surface on Gα~q~to encompass mainly β2 strand, α2 and α3 helices \[[@B50]\]. Since the putative PLCβ-interacting domain of Gα~16~is in proximity of the TPR1-interacting β3 region, we asked if activation of Ras and PLCβ can occur independently. The chimeras were transiently expressed in the absence or presence of the G~i~-coupled A~1~R and then assayed for IP formation with or without 10 μM CHA. Predictably, CHA-induced IP formation was observed with transfectants co-expressing Gα~16~, N30, C25, or C44 (Table [2](#T2){ref-type="table"}). Chimeras with parts of the PLCβ-interacting regions of Gα~16~replaced by cognate Gα~z~sequences should exhibit impaired ability to regulate PLCβ. Such chimeras include N246, N266, N295, C272, C219, C186, C174, C164, N188-C164, and N200-C164. Indeed, all ten chimeras failed to stimulate PLCβ in response to CHA (Table [2](#T2){ref-type="table"}), although CHA was capable of inhibiting cAMP formation in the transfectants (data not shown). The putative PLCβ-interacting region of Gα~16~is intact in N102, N155, N188, N200, N210, zβ2β3, and zβ3, and hence these chimeras are expected to support A~1~R-mediated IP formation. However, only transfectants harboring N188, zβ2β3 or zβ3 responded to CHA with a significant increase in IP formation (Table [2](#T2){ref-type="table"}). The lack of response to CHA challenge may be attributed to impairment in receptor/G protein recognition. To exclude such a possibility, we tested the ability of the constitutively active mutants of the chimeras to stimulate PLCβ. Those mutant chimeras with the PLCβ-interacting region disrupted or replaced by Gα~z~residues did not exhibit any stimulation of PLCβ, while Gα~16~QL and the previously characterized mutants such as C44 efficiently induced IP formation in the transfectants (Table [2](#T2){ref-type="table"}). Among the mutant chimeras with the α2-β4-α3-β5 region intact, only N188QL, N200QL, zβ2β3QL and zβ3QL constitutively stimulated the PLCβ activity (Table [2](#T2){ref-type="table"}). The constitutive activity of N200QL suggests that the inability of N200 to mediate A~1~R-induced stimulation of PLCβ may be attributed to defective recognition of receptor. With the exception of N102, N155, and N210, the PLCβ-stimulating abilities of the chimeras were in general agreement with the predicted presence of the putative PLCβ-interacting region.

###### 

Ability of Gα~16/z~chimeras to stimulate IP~3~production in HEK 293 cells.

  *Construct*   *Intact PLCβ Domain*   ***A***~***1***~***R-induced IP accumulation***   *QL-induced IP accumulation*                        
  ------------- ---------------------- ------------------------------------------------- ------------------------------ -------------------- ---------------------------
  pcDNA1        N/A                    10 ± 3                                            11 ± 2                         1.1 ± 0.2            N/A
  Gα~16~        Yes                    23 ± 5                                            237 ± 13                       ***10.0 ± 0.6\****   ***7.8 ± 0.4***^***\#***^
  N30           Yes                    23 ± 4                                            81 ± 10                        ***3.5 ± 0.7\****    ***6.5 ± 0.4***^***\#***^
  N102          Yes                    17 ± 4                                            13 ± 4                         0.8 ± 0.2            1.1 ± 0.1
  N155          Yes                    13 ± 3                                            10 ± 1                         0.8 ± 0.1            1.0 ± 0.1
  N188          Yes                    19 ± 4                                            155 ± 13                       ***8.2 ± 0.3\****    ***4.2 ± 0.2***^***\#***^
  N200          Yes                    11 ± 3                                            15 ± 2                         1.3 ± 0.1            ***2.0 ± 0.2***^***\#***^
  N210          Yes                    12 ± 3                                            10 ± 2                         0.8 ± 0.2            1.3 ± 0.1
  N246          No                     10 ± 2                                            10 ± 1                         1.0 ± 0.1            0.8 ± 0.0
  N266          No                     27 ± 3                                            17 ± 2                         0.6 ± 0.3            1.2 ± 0.2
  N295          No                     9 ± 1                                             9 ± 1                          1.0 ± 0.1            0.9 ± 0.2
  C25           Yes                    15 ± 3                                            92 ± 7                         ***6.1 ± 0.5\****    ***4.1***^***a***^
  C44           Yes                    78 ± 11                                           183 ± 15                       ***2.3 ± 0.2\****    ***2.6 ± 0.1***^***\#***^
  C164          No                     9 ± 2                                             8 ± 3                          0.9 ± 0.3            1.3 ± 0.2
  C174          No                     13 ± 3                                            14 ± 9                         1.1 ± 0.1            1.4 ± 0.2
  C186          No                     4 ± 1                                             6 ± 2                          1.5 ± 0.5            1.4 ± 0.2
  C219          No                     7 ± 1                                             9 ± 2                          1.3 ± 0.3            1.2 ± 0.1
  C272          No                     8 ± 1                                             9 ± 1                          1.1 ± 0.1            1.2 ± 0.1
  zβ2β3         Yes                    21 ± 5                                            51 ± 2                         ***3.0 ± 0.4\****    ***4.3 ± 0.4***^***\#***^
  zβ3           Yes                    14 ± 1                                            79 ± 5                         ***5.6 ± 0.3\****    ***6.9 ± 0.4***^***\#***^
  N200-C164     No                     15 ± 1                                            19 ± 1                         1.3 ± 0.1            0.9 ± 0.2
  N188-C164     No                     13 ± 0                                            14 ± 1                         1.1 ± 0.0            1.0 ± 0.2
  Gα~z~         No                     10 ± 1                                            9 ± 3                          0.9 ± 0.3            1.1 ± 0.1

HEK 293 cells were co-transfected with A~1~R and pcDNA1 or the indicated Gα subunit. Transfectants were labeled with \[^3^H\]inositol (2.5 μCi/mL) in DMEM containing 5% FBS overnight. IP~3~formations were examined in the absence (basal) or presence of 10 μM CHA for 60 min. Fold stimulations were calculated as the ratios of CHA-induced to basal IP~3~accumulations or QL-induced to wild-type IP~3~accumulations. Data represent the mean ± S.D. of triplicate determinations of a single representative experiment, n = 3; significant responses are shown in bold and italic. Constructs containing an intact putative PLCβ binding domain (α2-β4-α3-β5 regions) of Gα~16~are marked with a \"Yes\".

\* CHA-stimulated IP~3~production is significantly greater than basal (DMSO vehicle); paired *t*-test, *p*≤ 0.05.

^***\#***^QL-stimulated IP~3~production is significantly greater than the corresponding wild-type activity; paired *t*-test, *p*≤ 0.05.

^*a*^QL-induced fold stimulation of 16z25 was extrapolated from \[[@B38]\].

To confirm that the PLCβ-interacting regions of Gα~16~-interaction are distinct from that of TPR1, two series of Gα~16~chimeras were tested. The first series contained chimeras harboring the putative PLCβ-interacting domains, including N188, N200, and N210. HEK 293 cells were cotransfected with PLCβ~2~and Gα~16~or a chimera and then subjected to co-immuniprecipitation using antisera against either Gα~16~or PLCβ~2~. Interaction between PLCβ~2~and Gα~16~was clearly evident, with Gα~16~QL generating a stronger interaction with PLCβ~2~(Figure [8A](#F8){ref-type="fig"}). Chimeras N188, N200, and N210 were all capable of being co-immunoprecipitated with PLCβ~2~. Another set of chimeras including C164, C174, and C186 (the mirror images of the first series) was similarly tested (Figure [8B](#F8){ref-type="fig"}). Due to the replacement of the putative PLCβ-interacting regions with sequences of Gα~z~, these chimeras were expected not to interact with PLCβ~2~. Indeed, even with successful expression of the chimeras and PLCβ~2~, no PLCβ~2~interaction was detectable for these chimeras (Figure [8B](#F8){ref-type="fig"}). These results support the notion that the β3 region of Gα~16~is dispensable for the interaction with PLCβ (e.g. C164).

![**PLCβ~2~binds to Gα~16~via the α2-β4-α3-β5 regions that are distinct from the β3 domain required by TPR1**. (A-B) HEK 293 cells were co-transfected with PLCβ~2~and the wild-type or constitutively active mutants of Gα~16~, N188, N200, N210 (A), C164, C174, or C186 (B). Cell lysates were immunoprecipitated with anti-Gα~16~or anti-PLCβ~2~antisera and analyzed as described in Figure 2. Data shown represent one of three sets of immunoblots; two other sets yielded similar results.](1472-6807-11-17-8){#F8}

Since several chimeras can apparently activate Ras through TPR1 despite their inability to stimulate PLCβ, they represent useful tools in delineating complex signaling networks such as those for the regulation of STAT3 and NFκB. If these chimeras can induce the phosphorylation and activation of STAT3 and NFκB, then it would imply that PLCβ activity is not essential. Conversely, a lack of activity on STAT3 and NFκB by these chimeras would indicate that PLCβ action is required. Transfectants co-expressing the chimeras and A~1~R were stimulated with CHA, and the phosphorylation of STAT3 and inhibitor of κB kinase (IKK) monitored by western blot analysis using phosphoprotein-specific antibodies. As shown in Table [3](#T3){ref-type="table"}, chimeras with dual TPR1/Ras and PLCβ activating capabilities effectively mediated CHA-induced STAT3 (at Tyr^705^and Ser^727^) and IKK phosphorylations, with magnitudes similar to those of Gα~16~. These chimeras included N30, N188, C25, C44, zβ2β3, and zβ3. N200 failed to mediate the CHA-induced STAT3 phosphorylation but supported the IKK phosphorylation (Table [3](#T3){ref-type="table"}). TPR1-interacting chimeras which lack PLCβ activity (N102, N155, C164, N188-C164, and N200-C164) were unable to support CHA-induced phosphorylation of STAT3 and IKK (Table [3](#T3){ref-type="table"}). Because ERK is required for Gα~16~-mediated STAT3 and NFκB activation \[[@B36],[@B37]\], we further tested the ability of the chimeras to mediate ERK phosphorylation. The profile of ERK phosphorylation mediated by the chimeras closely resembled those for STAT3 and IKK (Table [3](#T3){ref-type="table"}). Chimeras lacking both PLCβ and TPR1/Ras activities, including N210, N246, N266, N295, C174, C186, C219, and C272, did not support any of the CHA-induced responses, whereas N30, N188, N200, C25, C44, zβ2β3, and zβ3 mediated CHA-induced ERK phosphorylation (Table [3](#T3){ref-type="table"}).

###### 

Gα~16/z~chimera-mediated phosphorylations of STAT3 (both Tyr^705^and Ser^727^), IKK, and ERK in HEK 293 cells.

  *Construct*   *TPR1/Ras Interaction*   *PLCβ*     *Fold Stimulation of Protein Phosphorylation*                                           
  ------------- ------------------------ ---------- ----------------------------------------------- ------------------- ------------------- -------------------
  pcDNA1        N/A                      N/A        1.0 ± 0.0                                       1.0 ± 0.0           1.2 ± 0.1           1.1 ± 0.1
  Gα~16~        Yes                      Yes        ***2.3 ± 0.3\****                               ***2.0 ± 0.1\****   ***2.4 ± 0.3\****   ***2.6 ± 0.1\****
  N30           Yes                      Yes        ***1.7 ± 0.1\****                               ***1.7 ± 0.2\****   ***1.7 ± 0.2\****   ***1.9 ± 0.1\****
  N102          Yes                      No         1.2 ± 0.1                                       1.1 ± 0.1           1.2 ± 0.0           1.3 ± 0.1
  N155          Yes                      No         1.1 ± 0.0                                       1.1 ± 0.1           1.2 ± 0.0           1.5 ± 0.0
  N188          Yes                      Yes        ***1.7 ± 0.0\****                               ***1.4 ± 0.1\****   ***1.9 ± 0.2\****   ***2.2 ± 0.1\****
  N200          Yes                      Yes^*a*^   0.9 ± 0.0                                       1.1 ± 0.1           ***1.6 ± 0.2\****   ***1.9 ± 0.1\****
  N210          No                       No         0.9 ± 0.1                                       0.9 ± 0.0           1.0 ± 0.0           1.1 ± 0.0
  N246          No                       No         1.1 ± 0.1                                       1.1 ± 0.1           1.0 ± 0.0           1.1 ± 0.1
  N266          No                       No         1.4 ± 0.3                                       1.1 ± 0.0           1.2 ± 0.2           1.3 ± 0.1
  N295          No                       No         1.0 ± 0.1                                       0.9 ± 0.0           1.0 ± 0.1           1.1 ± 0.0
  C25           Yes                      Yes        ***1.7 ± 0.1\****                               ***1.5 ± 0.1\****   ***1.6 ± 0.1\****   ***2.2 ± 0.0\****
  C44           Yes                      Yes        ***1.6 ± 0.0\****                               ***1.4 ± 0.0\****   ***1.5 ± 0.1\****   ***1.8 ± 0.0\****
  C164          Yes                      No         0.9 ± 0.1                                       1.0 ± 0.1           1.0 ± 0.0           1.3 ± 0.0
  C174          No                       No         1.1 ± 0.1                                       0.9 ± 0.0           0.6 ± 0.1           1.2 ± 0.2
  C186          No                       No         0.9 ± 0.1                                       1.1 ± 0.2           1.0 ± 0.1           1.3 ± 0.1
  C219          No                       No         1.1 ± 0.1                                       1.1 ± 0.2           1.3 ± 0.2           1.2 ± 0.1
  C272          No                       No         1.0 ± 0.1                                       0.9 ± 0.1           1.1 ± 0.1           0.8 ± 0.0
  zβ2β3         No                       Yes        ***1.6 ± 0.1\****                               ***1.5 ± 0.1\****   ***1.5 ± 0.1\****   ***2.2 ± 0.2\****
  zβ3           No^*b*^                  Yes        ***2.1 ± 0.2\****                               ***1.9 ± 0.1\****   ***2.0 ± 0.2\****   ***2.7 ± 0.1\****
  N200-C164     Yes                      No         1.0 ± 0.1                                       1.1 ± 0.1           0.9 ± 0.1           1.2 ± 0.0
  N188-C164     Yes                      No         1.0 ± 0.0                                       0.9 ± 0.1           1.0 ± 0.1           1.2 ± 0.0
  Gα~z~         No                       No         1.0 ± 0.0                                       0.9 ± 0.0           1.1 ± 0.0           1.1 ± 0.2

HEK 293 cells were co-transfected with adenosine A~1~R and pcDNA1 or the indicated Gα subunit. Transfectants were serum starved overnight in the presence of 100 ng/mL of PTX and then challenged with 10 μM CHA for 15 min. Cell lysates were then resolved and immunoblotted against various specific antibodies. Results are expressed as fold stimulation over the basal (DMSO vehicle), n = 3; significant responses are shown in bold and italic. Constructs shown to co-immunoprecipitate with FLAG-TPR1 or stimulate PLCβ activity (Table 2) are marked with a \"Yes\".

\* CHA-stimulated phosphorylation of the target protein is significantly greater than the basal; paired *t*-test, *p*≤ 0.05.

^*a*^significant PLCβ activation observed with the QL mutant only (see Table 2).

^*b*^Very weak association with TPR1 was detected in co-immunoprecipitation assays (Figure 9).

Finally, we employed luciferase reporter gene assays to demonstrate transcriptional regulation of STAT3 and NFκB by those chimeras that possess dual TPR1/Ras and PLCβ activating capabilities. In agreement with our previous studies \[[@B36],[@B37]\], CHA induced STAT3- and NFκB-driven luciferase activities in transfectants co-expressing Gα~16~but not Gα~z~(Table [4](#T4){ref-type="table"}). N30, N188, N200, C25, C44, and zβ3 chimeras all supported CHA-induced STAT3- and NFκB-driven luciferase activities, whereas no transcriptional activation was observed in transfectants co-expressing chimeras that failed to mediate STAT3, IKK, and ERK phosphorylations (Table [4](#T4){ref-type="table"}). Collectively, these studies demonstrate that dual TPR1/Ras and PLCβ activating capabilities of Gα~16~may be essential for its regulation of complex signaling networks such as those for the activation of STAT3 and NFκB.

###### 

Gα~16/z~chimera mediated STAT3-driven and NFκB-driven luciferase activities.

  *Construct*   *STAT3-driven Luciferase Fold Stimulation*   *NFκB-driven Luciferase Fold Stimulation*
  ------------- -------------------------------------------- -------------------------------------------
  pcDNA1        1.0 ± 0.0                                    1.1 ± 0.1
  Gα~16~        ***2.4 ± 0.1\****                            ***3.0 ± 0.2\****
  N30           ***1.7 ± 0.2\****                            ***2.1 ± 0.2\****
  N102          0.9 ± 0.1                                    1.3 ± 0.1
  N155          1.0 ± 0.0                                    1.3 ± 0.0
  N188          ***1.9 ± 0.2\****                            ***1.9 ± 0.2\****
  N200          ***1.5 ± 0.0\****                            ***1.7 ± 0.1\****
  N210          1.2 ± 0.1                                    1.2 ± 0.1
  N246          0.9 ± 0.1                                    1.2 ± 0.1
  N266          1.1 ± 0.1                                    1.2 ± 0.1
  N295          1.2 ± 0.2                                    1.1 ± 0.1
  C25           ***1.8 ± 0.1\****                            ***2.0 ± 0.1\****
  C44           ***1.6 ± 0.0\****                            ***1.9 ± 0.2\****
  C164          1.2 ± 0.0                                    1.3 ± 0.2
  C174          1.2 ± 0.1                                    1.2 ± 0.1
  C186          1.2 ± 0.0                                    1.3 ± 0.1
  C219          1.3 ± 0.2                                    1.2 ± 0.1
  C272          1.1 ± 0.1                                    1.2 ± 0.1
  zβ3           ***1.7 ± 0.2\****                            ***2.4 ± 0.0\****
  N200-C164     1.2 ± 0.1                                    1.0 ± 0.1
  N188-C164     1.2 ± 0.1                                    1.3 ± 0.0
  Gα~z~         1.1 ± 0.0                                    1.2 ± 0.0

HEK 293 cells were co-transfected with adenosine A~1~R, pSTAT3-luc/pNFκB-luc, and pcDNA1 or the indicated Gα subunit. Transfectants were serum starved for 4 h in the presence of 100 ng/mL of PTX and then challenged with 10 μM CHA overnight. Cell lysates were analyzed for luciferase activity. Data represent the mean ± S.D. of triplicate determinations, n = 3; significant stimulations are shown in bold and italic. \* CHA-stimulated protein phosphorylation is significantly greater than the basal; paired *t*-test, *p*≤ 0.05.

Discussion
==========

Protein-protein interactions are central to the functions of Gα subunits and each Gα subunit has to coordinate such interactions in a timely manner according to its guanine nucleotide binding state. Once activated, the GTP-bound Gα subunit has a limited time-span to regulate downstream effectors before its intrinsic GTPase activity turns it back to the inactive GDP-bound state, a process which can occur rapidly in the presence of RGS proteins. Hence, simultaneous regulation of multiple signaling pathways by activated Gα~16~is desirable but this entails the deployment of different binding surfaces. Although Ras can be activated indirectly by PLCβ signaling, our results provide a structural basis for Gα~16~to stimulate Ras through interaction with TPR1 instead of PLCβ. Moreover, functional analyses of Gα~16/z~chimeras reveal that dual stimulation of TPR1/Ras and PLCβ may be essential for Gα~16~to activate downstream transcription factors such as STAT3 and NFκB.

The extensive array of Gα~16/z~chimeras has enabled us to pinpoint the TPR1-interacting domain to the β3 region (and also possibly β2 as well) of Gα~16~. The β2-β3 region lies between the Switch I (mainly β2 strand) and II (mainly α2 helix) regions \[[@B56]\] and is accessible for protein-protein interaction (Figure [9A](#F9){ref-type="fig"}). Since activation of the Gα subunit alters the conformation of several switch regions drastically, proteins like PLCβ that bind to the Switch regions will interact with the GTP-bound active state much effectively than the GDP-bound basal state of the Gα subunit (Figure [8](#F8){ref-type="fig"}). However, the differences of the interactions between TPR1 and Gα~16~WT or Gα~16~QL are comparably smaller, and TPR1 can obviously bind to Gα~16~WT. Such observation implies that TPR1 may bind to Gα~16~at regions with relatively less drastic conformational changes. Our results suggested that the β3 strand of Gα~16~alone appears to be sufficient for the interaction with TPR1. The mere incorporation of the β3 region of Gα~16~confers upon Gα~z~the ability to bind TPR1 (N200-C164 chimera). N200-C164 has the amino acid sequence ^201^KTNLRIVDVG from Gα~16~inserted into a Gα~z~backbone, but only the first six residues are different from the corresponding Gα~z~sequence (^194^ELTFKMVDVG). Based on the crystal structure of Gα~i1~\[[@B43]\], molecular modeling of Gα~z~reveals that Glu^194^is located at the \"hook-shaped\" β2-β3 turn (Figure [9B](#F9){ref-type="fig"}), which is often composed of two oppositely charged residues flanked by two interacting hydrophobic residues except Gα~16~, with a threonine following the Lys^201^. The predicted β2-β3 turn of N200-C164 showed a more widened conformation (Figure [9B-C](#F9){ref-type="fig"}), which presumably forms a characteristic microdomain on Gα~16~for TPR1 interaction. The fact that the chimera zβ3 exhibited residual binding to TPR1 (Figure [6C](#F6){ref-type="fig"}) suggested that other regions like the β2 strand may also participate in the binding of TPR1 because its removal in the zβ2β3 chimera can further suppress TPR1 binding as compared to zβ3 (Figure [6C](#F6){ref-type="fig"}). Since several chimeras failed to generate a response in all of the functional assays, these chimeras might not be able to adopt the active conformation properly and it remains possible that additional residues other than the β3 region may bind to TPR1.

![**Molecular modeling of Gα subunits and the predicted conformational changes of the β2/β3 loop**. (A) Left: A molecular model of Gα~16~is depicted with the helical and GTPase domains highlighted in indigo and dark slate grey, respectively. Regions colored in yellow are the surface-exposing secondary structures that interact with PLCβ, while the TPR1-interacting β3 strand is in magenta. Right: The model is turned 90° clockwise horizontally to show the highlighted residues on α3 helix and the β2-β3 loop in a different orientation. (B) Models of Gα~z~(white) and N200-C164 (magenta) for the predicted conformational changes by mutating the β2-β3 loop of Gα~z~are depicted in tube-like carbon backbone. Side chains of the residues are colored according to the root mean square deviations (RMSD) between these residues on the two models. Blue and red colors represent the least and greatest deviations, respectively. The scale bar shows the corresponding RMSD range. (C) The β2-β3 loop of Gα~z~and N200-C164 are shown in the same orientations as in (B) but with the carbon backbone, side chains and the accessible molecular surfaces in the same colors to visualize the overall deviations in molecular surfaces and volumes caused by the mutations.](1472-6807-11-17-9){#F9}

Although the chimeras used in the present study were not tailored for the mapping of the PLCβ-interacting domain of Gα~16~, they nonetheless proved useful in locating the overall site for the binding of PLCβ. As in the case of Gα~q~\[[@B49],[@B50]\], the regions comprising of β2, β3, α2, and α3 are likely to form the PLCβ-interacting surface of Gα~16~(Figure [1](#F1){ref-type="fig"}) because chimeras with one or more of these regions disrupted all failed to stimulate IP formation (Table [2](#T2){ref-type="table"}). A more interesting observation is that chimeras including N102, N155, N200, and N210 could not activate PLCβ at all, and only the constitutively active form of N200 could stimulate PLCβ weakly, whereas the chimera N188 recapitulates the PLCβ-activating capability. N102 and N155 contained all the putative PLCβ-interacting domains and yet could not activate PLCβ, albeit both interacted with TPR1 and activated Ras. One plausible explanation is that both chimeras have a hybrid helical domain (αA-αG; Figure [3A](#F3){ref-type="fig"}) which may affect its structural and functional integrity. Indeed, all Gα~16/z~chimeras that can stimulate PLCβ activity (e.g., C44 and N188) contain a contiguous helical core (αA-αF helices) in addition to the putative PLCβ-interacting domains. An early study of Gα~s~suggested that its helical domain could function as an internal GAP for the GTPase domain \[[@B57]\], and the intra-molecular interaction between the GTPase and helical domains was proven to be essential for guanine nucleotide binding and receptor-mediated activation \[[@B58],[@B59]\]. Furthermore, the αC-αD loop of Gα subunits has been recognized as Switch IV which shows significant conformational changes in different guanine nucleotide-binding states and could reduce the nucleotide exchange rate when mutated \[[@B60]\]. It is therefore possible that a hybrid helical domain may impede the activation of PLCβ by the Gα~16/z~chimeras. The sudden regain of PLCβ-activating property of N188 which contains a helical domain completely derived from Gα~z~also implies that structural integrity of the helical domain is critical for PLCβ activation. As revealed in the very recent crystal structure of Gα~q~-PLCβ3 \[[@B50]\], the β2 and β3 strands of Gα~q~interact extensively with the C2 domain of PLCβ3, and these two strands also heavily contribute to the overall scaffold of the GTPase domain. Replacement of one or both of them, as in the N200 and N210 chimeras, might disrupt PLCβ interaction severely. Nonetheless, N200 can successfully form a heterotrimer with FLAG-tagged Gβγ dimer in co-immunoprecipitation experiment (unpublished data), excluding the possibility of improper folding of the chimera.

A molecular model of Gα~16~is constructed by homologous modeling based on the crystal structure of Gα~q~to visualize the potential interacting surfaces for PLCβ and TPR1. Except for the unusually long α4-β6 loop and differences in the N-terminal helix (not shown in the model), Gα~16~basically fit very well to the structure of Gα~q~. Assuming that Gα~16~utilizes domains similar to those of Gα~q~for the binding of PLCβ \[[@B49]\], it is entirely feasible for Gα~16~to simultaneously regulate PLCβ and TPR1. As shown in the right panel of Figure [9A](#F9){ref-type="fig"}, the critical PLCβ-interacting residues are clustered mostly on the left hand side of the GTPase domain of Gα~16~(yellow-colored), while the putative TPR1-interacting β3 region is located in the lower quadrant of the right hand side without severe overlap with the PLCβ-interacting region. Preliminary co-immunoprecipitation studies indeed suggest the existence of Gα~16~/PLCβ and PLCβ/TPR1 complexes (unpublished data). Further studies will be required to confirm if a Gα~16~/PLCβ/TPR1 complex truly exists. TPR motif-containing adaptors such as Rapsyn are known to cluster signaling molecules for the efficient propagation of signals \[[@B61]\]. It is conceivable that TPR1 may serve a similar function in G protein pathways. Its lack of association with Gα~13~, Gα~t1~\[[@B6]\] and Gα~z~(Figure [2B](#F2){ref-type="fig"}) suggests that TPR1 can selectively link G protein signals to Ras-dependent pathways. For those that can interact with TPR1, it remains to be determined if binding to TPR1 confers upon them the same repertoire of signaling capabilities.

The distinct locations for PLCβ- and TPR1-interacting regions infer that Gα~16~can regulate them independently. Indeed, we have demonstrated that some chimeras (e.g., N102, N155, C164, N188-C164, and N200-C164) can bind TPR1 (Figures [3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}, and [6](#F6){ref-type="fig"}) and induce Ras activation (Figure [7](#F7){ref-type="fig"}) even though they lack the ability to stimulate PLCβ (Table [2](#T2){ref-type="table"}). This raises an interesting possibility that, depending on the composition of the signaling modules within a cell, activation of Gα~16~may differentially regulate TPR1/Ras and PLCβ signaling pathways. Both Ras and PLCβ activities are apparently required for the regulation of STAT3 and NFκB \[[@B36],[@B37]\] , but it is not clear if the two components are arranged in parallel or in series. Given that the activation of STAT3 and NFκB could only be detected with chimeras possessing the ability to activate both Ras and PLCβ, it would seem that the two pathways are independently required for the regulation of STAT3 and NFκB. The need for multiple input signals increases signaling fidelity and specificity as well as ensuring a stringent control of transcription.

The possibility of Gα~16~to bind PLCβ and TPR1 simultaneously raises some interesting questions regarding the fidelity of G protein signals. One concern is whether the two signaling pathways can be regulated independently. Stimulation of PLCβ by GPCR can be mediated via members of the Gα~q~subfamily \[[@B62],[@B63]\] or through the Gβγ dimer \[[@B64],[@B65]\], with the latter restricted primarily to some isoforms of PLCβ. Like Gα~16~, both Gα~q~\[[@B6]\] and Gα~14~(unpublished data) can interact with TPR1. Since many ligands that act on G~q~-coupled receptors are mitogenic \[[@B10],[@B66]\], linkage through Gα~q~/TPR1 provides a means for the efficient stimulation of the Ras/Raf/MEK/ERK cascade for cell proliferation. Given that both PLCβ and TPR1 are ubiquitously expressed, the ability of Gα~16~as well as other Gα~q~subfamily members to selectively activate one of the two pathways may have to rely on alternative means of signal segregation, such as spatial orientation \[[@B67]\], formation of macromolecular signaling complexes \[[@B68]\], and compartmentalization of signaling components \[[@B69]\]. Attachment of the Gα~q~subunit to the lipid bilayer \[[@B70]\], as well as its targeting to plasma membrane microdomains and to intracellular organelles \[[@B71]\], have been shown to affect Gα~q~signaling. It should also be noted that the presence of p63RhoGEF can affect the binding of PLCβ and TPR1 to Gα~16~and differentially inhibit their signaling \[[@B25]\]. The p63RhoGEF-interacting domain on Gα~16~has yet to be elucidated, but is expected to encompass the α2-β4-α3-β5 regions and the C-terminal α5 helix based on the crystal structure of Gα~q~-p63RhoGEF-RhoA complex complex (Figure [1](#F1){ref-type="fig"}) \[[@B13]\]. In this regard, the Gα~16/z~chimeras represent useful tools to confirm such a prediction.

Conclusions
===========

This study provided evidence for the importance of the β3 strand of Gα~16~for the interaction with TPR1 and subsequent activation of Ras, but the β3 strand appears to be dispensable for PLCβ interaction. The integrities of both helical and GTPase domains are essential for PLCβ activation. Gα~16~can signal through TPR1/Ras and PLCβ simultaneously and independently to regulate transcriptional events involving STAT3 and NFκB by utilizing different structural domains to bind TPR1 and PLCβ. Overall, Gα~16~is able to interact with multiple molecular partners to convey different streams of signal transduction.
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